Introduction {#sec1-1}
============

Urinary tract infection (UTI) is said "nosocomial" or "nosocomially acquired" (NUTI or NAUTI) when it is acquired in any health-care institution or, more generally, when it is related to patient management.\[[@ref1]\] Nosocomial UTIs account for 37.5% of all Hospital-acquired infections.\[[@ref2]\] With regard to the etiological agents of UTIs, bacterial species are prevalent, particularly among patients who use urinary catheters.\[[@ref3]\] UTIs caused by fungi, frequently associated with medical devices, have increased and caused great morbidity and mortality among nosocomial patients.\[[@ref4]\] Although Candida albicans is still being isolated predominantly, the prevalence of *Trichosporon* has increased greatly.\[[@ref5]\] Genus *Trichosporon* is considered emerging pathogens in hospitalized patients.\[[@ref6]\] There are only sporadic reports of UTI caused by *Trichosporon asahii* reported from India.

*Trichosporon* species are widely distributed in nature and can occasionally belong to the human microbiota. They cause white piedra and onychomycosis in immunocompetent host as well as various localized and disseminated invasive infections in immunodeficient hosts. Virulence factors for trichosporonosis include glucuronoxylomannan in cell wall, proteases, phospholipases, and the ability to form biofilms. They form true mycelia, blastoconidia, and arthroconidia. Virulence factors and morphological structures may be exhibited differently in different species. Their ubiquity and biofilm formation may create confusion between colonized and truly infected patients. Invasive trichosporonosis may be confused with disseminated candidiasis. Although invasive trichosporonosis has been studied; however, there are no specific guidelines for clinical interpretation of *Trichosporon* recovery in urine.\[[@ref7]\] Azotemia and aggravation of renal dysfunction leading to renal failure may rarely occur.\[[@ref8]\]

At present, there are 51 species of *Trichosporon*, 16 of which are able to cause human infections. *T. asahii* is the predominant species involved in systemic mycosis.\[[@ref9]\] The emergence of less common, but medically important opportunistic fungal pathogens has contributed to an increase in the rate of morbidity and mortality.\[[@ref10][@ref11]\]

We report six cases of UTI caused by *T. asahii* in severely ill patients in a tertiary care setup.

Case Reports {#sec1-2}
============

Case 1 {#sec2-1}
------

A 68-year-old diabetic and hypertensive female patient was admitted to the hospital with chronic kidney disease and referred for Double J-stent insertion. She was a known case of chronic kidney disease and ischemic heart disease. Her blood parameters were as follows: hemoglobin = 8 g/dl, total leukocyte count = 12,800/ml, urea = 150 mg/dl, creatinine = 3.9 mg/dl, and random glucose = 127 mg/dl.

During the stay in the hospital, the patient had an indwelling catheter. The catheter was inserted using sterile technique. She was treated with meropenem, ciprofloxacin along with antacids and multivitamins. After 5 days of stay, she developed UTI. She had pyrexia of 102°F.

Patient\'s urine collected using universal precautions. Urine wet mount showed plenty of pus cells, 2--4 epithelial cells and budding yeast cells. The urine sample was inoculated with a standard loop on blood agar and Urichrom agar (Himedia Laboratories, India) and incubated at 37°C. On blood agar tiny, white, dry, wrinkled colonies were observed \[[Figure 1](#F1){ref-type="fig"}\], and on urichrom agar blue, dry, wrinkled colonies were observed \[[Figure 2](#F2){ref-type="fig"}\] with a colony count of \>10^5^ cfu/ml. The Gram stain of the colony revealed septate hyphae with arthrospores and few budding yeast cells \[[Figure 3](#F3){ref-type="fig"}\]. The colony was subcultured on to Potato Dextrose Agar and incubated at 22°C and 37°C. At both, the temperatures colonies of yeast-like fungus were obtained in pure culture. After 5 days of incubation on Corn Meal Agar (CMA), abundant rectangular arthroconidia were seen \[[Figure 4](#F4){ref-type="fig"}\]. When the patient was on the same urinary catheter, two more samples were collected. Both the samples revealed the same picture. The yeast was identified as *T. asahii* with Gram stain, morphology on CMA, hydrolysis of urea, carbohydrate fermentation, and assimilation tests. The same was identified by Vitek 2 compact automated system (bioMeriux). For molecular identification, the isolate was sent to the National Culture Collection of Pathogenic Fungi (NCCPF), Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, which confirmed our identification.

![Tiny white, dry colonies on blood agar](JLP-10-464-g001){#F1}

![Blue, dry wrinkled, colonies on urichrom agar with a colony count of \>10^5^ CFU/ml after 24 h incubation at 37°C](JLP-10-464-g002){#F2}

![Grams stain of the colony showing hyphal forms with arthrospores and few budding yeast cells](JLP-10-464-g003){#F3}

![Corn meal agar showing pseudohyphae with blastoconidia of varying sizes and rectangular arthroconidia](JLP-10-464-g004){#F4}

Antifungal susceptibility testing was done by using Mueller-Hinton Agar with 2% Glucose and methylene blue (Himedia, India) for fluconazole, Itraconazole, voriconazole, Ketoconazole, and Amphotericin-B. The susceptibility of the strain was evaluated by the disk-diffusion method, in accordance with protocol M44-A of the clinical and laboratory standards institute. It was found that this isolate was sensitive to Itraconazole and voriconazole and resistant to fluconazole, Ketoconazole, and Amphotericin-B. Antifungal therapy with voriconazole and change of indwelling catheter subsequently lead to negative fungal growth in urine cultures.

Case 2 {#sec2-2}
------

*T. asahii* was isolated thrice from urine samples of a 42-year-old comatose patient who was admitted for follow-up and rehabilitation. She was a known case of hypertension and hypothyroidism. She underwent a surgery for left temporal, parietal intracranial bleed with IV extension. Her blood parameters were as follows, hemoglobin = 10.7 g/dl, total leukocyte count = 21,100/ml, urea = 81 mg/dl, creatinine = 0.9 mg/dl, and glucose random = 110 g/dl. The patient had an indwelling catheter throughout her stay in the hospital. The patient was on clindamycin, cefoperazone, levothyroxine, amlodipine, and antacids.

Urine microscopy revealed moderate number of pus cells and occasional yeast cells. The sample was subjected to culture, and pure, significant, white wrinkled colonies were isolated which showed true hyphae and arthroconidia on staining. The isolate was identified as *T. asahii* based on Grams staining, morphology on CMA, urea hydrolysis \[[Figure 5](#F5){ref-type="fig"}\], carbohydrate fermentation, and assimilation tests \[[Figure 6](#F6){ref-type="fig"}\] and the same was confirmed by Vitek 2 compact automated system (Biomerieux).

![Sabourauds dextrose broth showing pellicle formation and urease test positive](JLP-10-464-g005){#F5}

![Sugar assimilation test showing assimilation of dextrose, maltose, sucrose, galactose, and lactose sugars](JLP-10-464-g006){#F6}

Antifungal susceptibility testing revealed that the isolate was sensitive to Itraconazole, voriconazole and resistant to Amphotericin-B, fluconazole, and Ketoconazole \[[Figure 7](#F7){ref-type="fig"}\]. Prompt treatment with voriconazole and management for comorbidities lead to subsequently sterile urine cultures.

![Antibiotic susceptibility testing on Mueller-Hinton Agar with 2% glucose and methylene blue showing semiconfluent growth of the test isolate](JLP-10-464-g007){#F7}

Case 3 {#sec2-3}
------

Urine sample of a 53-year-old female patient with colon carcinoma and bilateral hydroureteronephrosis yielded the growth of *T. asahii* on three occasions. The patient underwent hemicolectomy and was on chemotherapy. The patient had a urinary catheter throughout her stay in the hospital. The patient was on treatment with Amoxyclav, Linezolid, and Levofloxacin in appropriate dosages along with antacids and multivitamins. Her blood picture showed hemoglobin = 6.9 mg/dl, total leukocyte count = 13,600/ml, urea = 72 mg/dl, and creatinine = 4.2 mg/dl.

Wet mount of the urine sample revealed moderate number of pus cells and budding yeast cells with pseudohyphae \[[Figure 8](#F8){ref-type="fig"}\]. Based on cultural and biochemical characteristics, the isolate was identified as *T. asahii* which is sensitive to voriconazole, fluconazole and resistant to Amphotericin-B, Itraconazole, and ketoconazole. Antifungal therapy with fluconazole was given, and urine sample sent for the culture after treatment which was found to be negative for the fungus.

![Wet mount of urine showing budding yeast cells, pseudohyphae and true hyphal forms](JLP-10-464-g008){#F8}

Case 4 {#sec2-4}
------

*T. asahii* was isolated thrice from urine samples of an 85-year-old male patient who was admitted for generalized weakness for 15 days' duration and was a known case of hypertension, diabetes mellitus, and asthma. Radiological investigations revealed right mild hydronephrosis with proximal ureteric calculus and left mild hydronephrosis with partial staghorn calculus. He was diagnosed as acute on chronic kidney failure and obstructive nephropathy. The patient had an indwelling catheter throughout his stay in the hospital. He was treated with ciprofloxacin, clindamycin, Amlong, Asthalin nebulization, insulin, and antacids. His blood parameters were as follows: hemoglobin = 12 g/dl, total leukocyte count = 16,500/ml, urea = 280 mg/dl, creatinine = 8 mg/dl, and glucose random = 120 mg/dl.

Urine microscopy revealed plenty of pus cells and budding yeast cells. Culture isolate was identified as *T. asahii* based on the cultural and biochemical characteristics which are sensitive to itraconazole, voriconazole and resistant to fluconazole, ketoconazole, and Amphotericin-B. The removal of urinary catheter, the management of comorbidities and treatment with voriconazole subsequently lead to sterile urine cultures.

Case 5 {#sec2-5}
------

*T. asahii* was isolated from urine on three occasions from a 60-year-old male patient who was admitted with the history of fever and abdominal pain from 15 days. He underwent cholecystectomy and was on treatment with cefoperazone and clindamycin. He was on indwelling catheter for 6 days' duration. His blood parameters were as follows: hemoglobin = 13 g/dl, total leukocyte count = 12,000/ml, urea = 81 mg/dl, creatinine = 1.2 mg/dl, and fasting blood sugar = 80 mg/dl. Urine microscopy showed 10--12 pus cells/HPF and few budding yeast cells. Culture yielded pure yeasty colonies which on Gram stain revealed true hyphae and arthroconidia. Based on culture morphology, biochemical reactions, and Vitek 2 identification, the isolate was identified as *T. asahii* which was sensitive to voriconazole, Itraconazole, fluconazole and resistant to Amphotericin-B and ketoconazole. Antifungal therapy with fluconazole and removal of indwelling catheter subsequently lead to negative fungal growth in urine cultures.

Case 6 {#sec2-6}
------

A 55-year-old female patient was involved in a road traffic accident and underwent right knee surgery with vancomycin and ciprofloxacin antibiotic coverage. She was on indwelling urinary catheter for 7 days' duration. Her blood picture showed hemoglobin = 13 g/dl, total leukocyte count = 13,700/ml, fasting and postprandial blood sugars 90 mg/dl and 140 mg/dl, respectively, urea = 40 mg/dl and creatinine = 0.9 mg/dl. Urine sample was sent for culture and sensitivity. Urine microscopy revealed plenty of pus cells with septate hyphae and arthroconidia. The culture isolate was identified as *T. asahii* through its, cultural characteristics, morphology on CMA, hydrolysis of urea, carbohydrate fermentation, and assimilation tests. The isolate was sensitive to fluconazole, itraconazole, voriconazole and resistant to Amphotericin-B, ketoconazole. Two more repeat urine analysis could not be done as the patient was discharged and lost to follow-up \[[Table 1](#T1){ref-type="table"}\].

###### 

Underlying conditions and risk factors among the study participants

![](JLP-10-464-g009)

Results {#sec1-3}
=======

Among six positive *T. asahii* UTI, four were found in female patients.

Positive cultures were more common among individuals \>50 years.

All patients were on indwelling urinary catheter with a mean duration of 18.8 days.

All patients received antibiotic therapy before the fungal infection. The most commonly used antibiotics were Beta-lactam group of antibiotics and fluoroquinolones.

Of the 6 cases, the presence of comorbid conditions such as diabetes in 33%, hypertension in 50%, anemia in 50%, and chronic kidney disease in 33% were seen.

With regard to the antifungal susceptibility testing, all the isolates were resistant to Amphotericin B and ketoconazole and sensitive to voriconazole. 83% of them were sensitive to Itraconazole, 50% of them were sensitive to fluconazole.

Discussion {#sec1-4}
==========

Our results indicate that the prevalence of *Trichosporon* spp. in urine cultures is more common among women compared to men with a mean age being 60 years. We observed that all patients were catheterized and were on broad-spectrum antibiotics and with other comorbid conditions.

In the present case series, a larger number of patients were of age group \>50 years. These individuals could possibly have chronic conditions associated with immunosuppression and increased susceptibility to atypical urinary infections.

In general, urinary infections in adults are more common among women. This increased susceptibility is due to anatomical conditions, i.e., shorter urethra that is in close proximity to the vagina and anus.\[[@ref12]\] This finding was corroborated by this study as 66.6% of the infections occurred in women. In contrary, a study done in Brazil showed 65% of *Trichosporon* UTI occurred in men.\[[@ref13]\]

Indwelling catheters compromises the natural barriers of the skin and mucosa, increasing the risk of opportunistic infections and complications, including UTIs.\[[@ref14]\] Fungal development among patients using indwelling catheters is facilitated by the formation of biofilm, which could explain the persistence of infection with *Trichosporon* spp.\[[@ref15]\] In our study, a similar finding was noted that all patients were on indwelling urinary catheter with a mean duration of 18.8 days. Multivariate analyses have emphasized that the duration of catheterization is the most important risk factor in the development of catheter-associated bacteriuria.\[[@ref16][@ref17][@ref18]\] Other risk factors include colonization of the drainage bag, catheter, and periurethral segment, diabetes mellitus, female gender, impaired renal function, poor quality of catheter care, including its insertion outside of an operating room and lack of antimicrobial therapy.\[[@ref19][@ref20][@ref21][@ref22]\]

The use of antibiotics in severely ill patients favors fungal development, particularly by yeasts, and the onset of opportunistic infections. Narrow and broad-spectrum antibiotics have broader mechanisms of action against bacteria when used in combination, and they selectively favor fungal growth in hospitalized patients.\[[@ref23]\] In our study, a relevant observation was seen that all patients used antibiotics, particularly cephalosporins and quinolones before infection.

Consistent with previous studies conducted in Brazil and Spain, there were susceptible populations commonly associated with *Trichosporon* infections in this study.\[[@ref7][@ref24]\]

All six patients were severely ill and elderly (\>50 years), were on antibiotic treatment and indwelling urinary catheter. All patients had various comorbidities, among which Hypertension and Anemia were maximum followed by Diabetes and Chronic Kidney disease.

Data on *T. asahii* antifungal susceptibility are limited, but azoles have good activity against the fungus. While amphotericin B has been shown to have a limited *in vitro* effect.\[[@ref25][@ref26]\] The isolates in the present case series also showed resistance to Amphotericin B and were found variably sensitive to azoles (fluconazole, Itraconazole, and voriconazole). With concerns about the emergence of antifungal resistance, it is essential that prophylactic and empiric antifungal therapy be based on appropriately designed clinical studies, particularly in high-risk patients. Further studies are needed to define optimal approaches to facilitate earlier treatment, which will improve patient outcomes.

Difficulties on different species identification as well as the lack of standardized sensitivity tests *in vitro*, contribute to the limited information available on epidemiology, diagnosis, and therapeutics of *Trichosporon* infections.

Standardization of the approaches for early detection of this etiological agent is essential to ensure appropriate and effective treatment of severely ill patients. Standardization is required to differentiate between colonization and infection by *Trichosporon* spp., particularly among patients on urinary catheters as in the present case series.

The limitations of this study include the fact it was conducted in a single center and the small sample size.

Conclusion {#sec1-5}
==========

Risks factors, such as presence of indwelling catheter, use of broad-spectrum antibiotics, and the presence of comorbid conditions such as diabetes mellitus, hypertension, chronic kidney disease, and anemia, predispose for the development of UTI by *T. asahii*.

Isolation of the same yeast in three consecutive urine samples with significant counts, along with a significant number of pus cells establishes *T. asahii* as an etiological agent of UTI. Furthermore, the clearance of the fungus from the urinary tract with the recovery of the patient following catheter removal and antifungal therapy further confirms *T. asahii* as the cause of UTI.\[[@ref5]\]
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